PASG · Forms 3, 4, 5
Insider trades at Passage BIO, Inc.
No open-market insider buys or sells at Passage BIO, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Passage BIO, Inc. (PASG) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Passage BIO, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% owner | Buy | 50,055 | $4.12 | $206K | Form 4 | |
| Dolan Sondhi | Director | Options or other derivatives | Form 4 | ||||
| Derrell Porter | Director | Options or other derivatives | Form 4 | ||||
| Thomas Richard Kassberg | Director | Options or other derivatives | Form 4 | ||||
| Sandip Kapadia | Director | Options or other derivatives | Form 4 | ||||
| Maxine Gowen | Director | Options or other derivatives | Form 4 | ||||
| Athena Countouriotis | Director | Options or other derivatives | Form 4 | ||||
| Kathleen Borthwick | CFO | Options or other derivatives | Form 4 | ||||
| William Chou | PRESIDENT AND CEO | Options or other derivatives | Form 4 | ||||
| William Chou | PRESIDENT AND CEO | Option exercise | 10,000 | Form 4 | |||
| William Chou | PRESIDENT AND CEO | Sell | 4,076 | $18.44 | $75K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.